Ligand Partner Eisai Receives Approval in Japan for Injection Formulation of Antiepileptic Drug Fycompa®

Fycompa® is the 16th Captisol-enabled™ product approved worldwide

...

Related Keywords

China ,Japan ,United States ,Japanese ,Acrotech Biopharma ,Amgen Kyprolis ,Valentino Stella ,Todd Davis ,Ligand Pharmaceuticals ,University Of Kansa Higuchi Biosciences Center ,University Distinguished Professor ,Eisai Co Ltd ,Ligand Pharmaceuticals Incorporated Nasdaq ,Amgen ,Catalyst Pharmaceuticals Inc ,Japanese Ministry Of Health ,Exchange Commission ,Pfizer ,Gilead Sciences ,Baxter International ,Eisai Tsukuba Research Laboratories ,Ligand Pharmaceuticals Incorporated ,Japanese Ministry ,Tsukuba Research ,Catalyst Pharmaceuticals ,Kansa Higuchi Biosciences Center ,Sage Therapeutic ,Private Securities Litigation Reform Act ,Markets ,